TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Mechanical behavior of materials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optical properties of materials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implantation of a Pacemaker at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Palatability of new flavour - Overall
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of heart defect characteristics detectable
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean apnea time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early acute kidney injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Combined event
Endpoint domain: Adverse events/effects
Primary endpoint: Drug tolerance of the first cycle
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR) at Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain subscore on the KOOS Survey
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: acute neurological injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mechanical power normalized to predicted body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measure of Semantic Knowledge (MSK)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean sway path of the center of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean sway velocity of the center of pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal reflex excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Co-activation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fat Grafting Volume Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative major morbidities
Endpoint domain: Adverse events/effects
Primary endpoint: Early mortality (<90 day)
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with complete response (CR) and stringent complete response (sCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of response (DOR) after CAR-T infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of Study Activities (Recruitment)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Study Activities (Attrition)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to Study Activities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence, causality, and severity of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in percent weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Habit Automaticity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concordance of quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants reporting solicited local and systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Neonates who do not require additional seizure treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Treatment satisfaction, first treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Treatment satisfaction, second treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of household contacts initiated on tuberculosis preventive treatment within 4 weeks
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Patients who Received Inclisiran Dose 2 and 3 Within Specified Time Intervals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: On-time Surveillance Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: total cumulative dosage of Gonadotropins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total number of matured oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: total number of good quality blastocyst
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in nitrite and leukocyte esterase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breath VOCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of clinical anastomotic leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Neurogenic Paraosteoarthropathies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Discharge location after TKA
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time Span to Achieve Safe and Efficient Oral Feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fitness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting blood samples, post prandial and HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Estradiol blood test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Frequency of enough Tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The speed of successful non-invasive electrical stimulation deployment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with device related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: rCBF in the hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of Validity of the PREM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of Reliability of the PREM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of Responsiveness of the PREM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of Feasibility of implementing the PREM in clinical practice
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intraoperative surgical field optimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: No conversions to open NSM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain associated with tooth movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral fructose handling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Apathy Evaluation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportions of subjects achieving EASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportions of subjects achieving IGA score of 0/1 point and a decrease of ≥ 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Vaccine delivery success
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: hyperglycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of mental health related posts
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Engagement with intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change of Symptom Checklist-90-Revised (SCL-90-R)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency and Severity of Treatment-Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of CRD-TMH-001
Endpoint domain: Adverse events/effects
Primary endpoint: Boston Carpal Tunnel Questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes to the BLS Knowledge Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes to the BLS attitude Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The observable BLS skill checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optic nerve sheath diameter measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of collisions with the environment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of tissue invasive disease
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Cross-sectional area of the spinal canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid status assessment in patients with AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: change in behavior problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in parental stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional capacity changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One year falls rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One year fall-related hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: One year fall-related fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One year fall-related death
Endpoint domain: Mortality/survival
Primary endpoint: Epigenetic aging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calprotectine rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of endocervical cytology sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of endocervical cell block sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of endocervical curettage sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive test for SARS-CoV-2
Endpoint domain: Adverse events/effects
Primary endpoint: change in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in baseline gender incongruence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence rate of Serious infections
Endpoint domain: Adverse events/effects
Primary endpoint: Pain intensity at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early distant metastases
Endpoint domain: Mortality/survival
Primary endpoint: Functional Efficacy measured by Oswestry Disability Index (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Events for Safety
Endpoint domain: Adverse events/effects
Primary endpoint: Overall response rate at 6 months (ORR6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periorbital Ecchymosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in mean response to physical activity in the renin-angiotensin system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative absorbed dose at different heights outside the NPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative absorbed dose at different heights outside the TLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative absorbed dose of the first operator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual task performance - 10 meter walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS 28 ESR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean kidney dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients performing at least 50% of expected daily treatments
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Accuracy of markerless tracking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of a parenting program
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline cortisol and ACTH hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from Baseline Test of Infant Motor Performance-TIMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline height measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline head circumference measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body temperature in Celsius
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulse per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygen saturation levels in %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Control of intra-operative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Survival without major morbidities
Endpoint domain: Mortality/survival
Primary endpoint: Change of lightness value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life Functional Assessment of Cancer Therapy-Lung
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Back pain functional scale changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of metabolic dysfunction associated steatotic liver disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk factors for metabolic dysfunction associated steatotic liver disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes of the circadian rhythm during admission by actigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of the circadian rhythm during admission by heart-rate-variation-analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Melatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes of Vitamin D level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pharmacokinetics of combination oral contraceptive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Sitting DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of ciprofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ciprofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous partial pressure of carbon dioxide (TcPCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton anxiety rating scale (HARS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-discharge adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: sensitivity of ViRADS SCORE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of ViRADS SCORE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High risk group of malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite outcome of all-cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Variation of radial vascular flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Variation of ulnar artery vascular flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Variation of interdigital arterial tree vascular flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Caregiver Strain Index
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in total distress as measured via DASS-21 total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in serum brain derived neurotrophic factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcomes in COPM scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of isolated intestinal crypts per biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of successful bile duct stone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urinary Incontinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychometric hepatic encephalopathy score (PHES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical decompensation and death
Endpoint domain: Mortality/survival
Primary endpoint: EuroQol Five Dimensions Questionnaire (EQ5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vitamins concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: solicited local adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: solicited systemic adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive accuracy of HVPG and ICG-r15 on PHLF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who consented to OS
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants who had both fallopian tubes removed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of additional minutes in the OR required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: attendance rate of participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of participants who completed the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Orocutaneous Fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Polysubstance Use Urinalysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysubstance Use Self Report
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Comfort With Lens
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median peak transpulmonary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Breathing rate accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulse rate accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Carotid Reocclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Platelet aggregation phenomena
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Symptomatic intracranial hemorrhage (sICH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in MADRS10 Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median of day hospital encounters or hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Median incidence of toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: LVEF %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Troponin.I (ng/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time of weaning from dobutamine infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient experience of the care pathway
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Western Ontario and McMaster Universities (WOMAC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utility-weighted modified Rankin scale scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Difference in expiratory oxygen concentration (FeO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes